Convergent evidence suggests that GSK3 is an important mediator of the DRD2-βArr2-AKT-GSK3 signaling pathway22–24 and that GSK3 plays critical roles in brain development and schizophrenia pathogenesis7,25–27. The gene discussed is DRD2; the disease is schizophrenia.